Modified cobratoxin    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
20Adrenoleukodystrophy1

20. Adrenoleukodystrophy    [ 49 clinical trials,   86 drugs,   (DrugBank: 29 drugs),   18 drug target genes,   112 drug target pathways]
Searched query = "Adrenoleukodystrophy", "Adrenomyeloneuropathy", "AMN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 49 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-002200-14-GB
(EUCTR)
17/10/200618/07/2005Randomised Placebo Controlled Trial of a Parenteral Modified Cobratoxin in Adrenomyeloneuropathy - Modified Cobratoxin Therapy in AdrenomyeloneuropathyRandomised Placebo Controlled Trial of a Parenteral Modified Cobratoxin in Adrenomyeloneuropathy - Modified Cobratoxin Therapy in Adrenomyeloneuropathy AdrenomyeloneuropathyProduct Name: modified cobratoxin
Product Code: RPI78M for injection
ReceptoPharm Inc.NULLNot RecruitingFemale: yes
Male: yes
20Phase 3United Kingdom